(Q55482860)

12 July 2018

title

A mouse/human chimeric anti-(ganglioside GD3) antibody with enhanced antitumor activities. (English)

1 reference

12 July 2018

author name string

K Shitara

1

1 reference

12 July 2018

Y Kuwana

2

1 reference

12 July 2018

K Nakamura

3

1 reference

12 July 2018

Y Tokutake

4

1 reference

12 July 2018

S Ohta

5

1 reference

12 July 2018

H Miyaji

6

1 reference

12 July 2018

M Hasegawa

7

1 reference

12 July 2018

N Hanai

8

1 reference

12 July 2018

publication date

1 June 1993

1 reference

12 July 2018

Cancer Immunology, Immunotherapy

published in

1 reference

12 July 2018

volume

36

1 reference

12 July 2018

page(s)

373-380

1 reference

12 July 2018

issue

6

1 reference

12 July 2018

https://scigraph.springernature.com/pub.10.1007/bf01742253

exact match

0 references

cites work

Reduced immunogenicity and improved pharmacokinetics of humanized anti-Tac in cynomolgus monkeys

1 reference

12 December 2020

Characterization of a human melanoma-associated ganglioside antigen defined by a monoclonal antibody, 4.2.

1 reference

12 December 2020

Convenient plasmid vectors for construction of chimeric mouse/human antibodies

1 reference

12 December 2020

Linkage of the four gamma subclass heavy chain genes

1 reference

12 December 2020

Antitumor effects of a novel monoclonal antibody with high binding affinity to ganglioside GD3.

1 reference

12 December 2020

Regression of cutaneous metastatic melanoma by intralesional injection with human monoclonal antibody to ganglioside GD2.

1 reference

12 December 2020

Isotype modulation of idiotypic expression in recombinant isotypic variants of MOPC 315.

1 reference

12 December 2020

Enhancement of antibody-dependent cytotoxicity with a chimeric anti-GD2 antibody.

1 reference

12 December 2020

Cloned human and mouse kappa immunoglobulin constant and J region genes conserve homology in functional segments

1 reference

12 December 2020

Immunorecognition of different ganglioside epitopes on human normal and melanoma tissues

1 reference

12 December 2020

Efficient expression of human beta-interferon in Namalwa KJM-1 cells adapted to serum-free medium by a dhfr gene coamplification method

1 reference

12 December 2020

Cell surface antigens of human malignant melanoma: definition of six antigenic systems with mouse monoclonal antibodies

1 reference

12 December 2020

Phase I trial of a mouse monoclonal antibody against GD3 ganglioside in patients with melanoma: induction of inflammatory responses at tumor sites

1 reference

12 December 2020

Biological activity of human-mouse IgG1, IgG2, IgG3, and IgG4 chimeric monoclonal antibodies with antitumor specificity

1 reference

12 December 2020

Surface antigens of melanomas and melanocytes defined by mouse monoclonal antibodies: specificity analysis and comparison of antigen expression in cultured cells and tissues

1 reference

12 December 2020

Phase I Trial of Multiple Large Doses of Murine Monoclonal Antibody CO17-1A. II. Pharmacokinetics and Immune Response1

1 reference

12 December 2020

Lipid Composition of Human Malignant Melanoma Tumors at Various Levels of Malignant Growth

1 reference

12 December 2020

Mouse monoclonal IgG3 antibody detecting GD3 ganglioside: a phase I trial in patients with malignant melanoma

1 reference

12 December 2020

Glycosphingolipids of human gliomas.

1 reference

12 December 2020

Detailed characterization of reactivities of anti-gastric cancer monoclonal antibodies to carbohydrate antigen

1 reference

12 December 2020

Human monoclonal antibody to ganglioside GM2 for melanoma treatment

1 reference

12 December 2020

Strong antitumor activities of IgG3 antibodies to a human melanoma-associated ganglioside

1 reference

12 December 2020

GD3, a prominent ganglioside of human melanoma. Detection and characterisation by mouse monoclonal antibody

1 reference

12 December 2020

Sequences at the somatic recombination sites of immunoglobulin light-chain genes

1 reference

12 December 2020

Expression of chimeric receptor composed of immunoglobulin-derived V regions and T-cell receptor-derived C regions.

1 reference

12 December 2020

Comparative studies on monoclonal antibodies raised against human gastric cancer for application to serum diagnosis of cancer

1 reference

12 December 2020

Ganglioside GM3:GD3 ratio as an index for the management of melanoma

1 reference

12 December 2020

Ganglioside-mediated modulation of cell growth. Specific effects of GM3 and lyso-GM3 in tyrosine phosphorylation of the epidermal growth factor receptor.

1 reference

12 December 2020

Gangliosides of human melanoma

1 reference

12 December 2020

1 reference

12 December 2020

Lipid composition of human neural tumors

1 reference

12 December 2020

Chimeric mouse-human IgG1 antibody that can mediate lysis of cancer cells

1 reference

12 December 2020

Mouse/human chimeric monoclonal antibody in man: kinetics and immune response

1 reference

12 December 2020

Expression of human beta-interferon in Namalwa KJM-1 which was adapted to serum-free medium

1 reference

12 December 2020

The nucleotide sequence of a human immnnoglobulin Cγlgene

1 reference

12 December 2020

Localization of the gangliosides GD2 and GD3 in adhesion plaques and on the surface of human melanoma cells

1 reference

12 December 2020

Ganglioside GD2 specific monoclonal antibody 3F8: a phase I study in patients with neuroblastoma and malignant melanoma

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF01742253

1 reference

12 July 2018

Dimensions Publication ID

0 references

1 reference

12 July 2018